Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways

Zhang,Shiyuan; He,Yang; Tong,Qingyi; Chen,Qianming; Wu,Xiaohua; Huang,Wen

doi:10.3892/mmr.2013.1273

Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways

Authors:
- Shiyuan Zhang
- Yang He
- Qingyi Tong
- Qianming Chen
- Xiaohua Wu
- Wen Huang
View Affiliations

Affiliations: Laboratory of Ethnopharmacology, Regenerative Medicine Research Center, Institute for Nanobiomedical Technology and Membrane Biology, West China Hospital/Medical School, Sichuan University, Sichuan 610041, P.R. China, State Key Laboratory of Oral Disease, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China
Published online on: January 11, 2013 https://doi.org/10.3892/mmr.2013.1273
Pages: 1038-1044

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Deltonin, a steroidal saponin isolated from Dioscorea zingiberensis Wright, exhibits high cytotoxic activity in cancer cells. In the present study, the effects of deltonin on cell proliferation and apoptosis were evaluated in the MDA‑MB‑231 human breast carcinoma cell line. Following treatment with deltonin, the viability of MDA‑MB‑231 cells was analyzed using MTT assay and apoptosis, mitochondrial membrane potential (∆Ψm) alternation and intracellular reactive oxygen species (ROS) generation was determined by flow cytometry. In addition, western blot analysis was performed to examine the expression of apoptosis‑associated proteins. The results demonstrated that deltonin induced apoptosis in MDA‑MB‑231 cells in a time‑ and concentration‑dependent manner. Apoptosis was associated with depolarization of ∆Ψm and time‑dependent ROS generation. Deltonin treatment also resulted in Bax upregulation, Bcl-2 downregulation, activation of caspase‑3 and ‑8 and poly (ADP ribose) polymerase cleavage. Decreased levels of phosphorylated extracellular signal‑regulated kinase (ERK) and phosphorylated AKT were also observed. Results indicate that the proliferation inhibitory effect of deltonin is associated with its apoptosis‑inducing effect, which may correlate with ROS‑mediated mitochondrial dysfunction as well as activation of the ERK/AKT signaling pathways. Therefore, deltonin may be a potential chemotherapeutic agent for the treatment of breast cancer.

View Figures

View References

1	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Lambert R, Sauvaget C and Sankaranarayanan R: Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer. 125:253–256. 2009. View Article : Google Scholar : PubMed/NCBI
3	Anderson BO, Shyyan R, Eniu A, et al: Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 Guidelines. Breast J. 12(Suppl 1): S3–S15. 2006.PubMed/NCBI
4	Gottesman MM: Mechanisms of cancer drug resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
5	Efferth T, Li PC, Konkimalla VS and Kaina B: From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
6	Chatterjee S, Kundu S and Bhattacharyya A: Mechanism of cadmium induced apoptosis in the immunocyte. Toxicol Lett. 177:83–89. 2008. View Article : Google Scholar
7	Pathak N and Khandelwal S: Role of oxidative stress and apoptosis in cadmium induced thymic atrophy and splenomegaly in mice. Toxicol Lett. 169:95–108. 2007. View Article : Google Scholar : PubMed/NCBI
8	Gupta S, Yel L, Kim D, et al: Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: a role of Bcl-2. Mol Cancer Ther. 2:711–719. 2003.PubMed/NCBI
9	Fan TJ, Han LH, Cong RS, et al: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
10	Reed JC: Mechanisms of apoptosis. Am J Pathol. 157:1415–1430. 2000. View Article : Google Scholar
11	Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
12	Desagher S and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
13	Li H, Zhu H, Xu CJ and Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
14	Green D and Kroemer G: The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8:267–271. 1998. View Article : Google Scholar : PubMed/NCBI
15	Moalic S, Liagre B, Corbière C, et al: A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett. 506:225–230. 2001. View Article : Google Scholar : PubMed/NCBI
16	Kaskiw MJ, Tassotto ML, Th'ng J and Jiang ZH: Synthesis and cytotoxic activity of diosgenyl saponin analogues. Bioorgan Med Chem. 16:3209–3217. 2008. View Article : Google Scholar : PubMed/NCBI
17	Kaskiw MJ, Tassotto ML, Mok M, et al: Structural analogues of diosgenyl saponins: synthesis and anticancer activity. Bioorgan Med Chem. 17:7670–7679. 2009. View Article : Google Scholar : PubMed/NCBI
18	Liu MJ, Yue PY, Wang Z and Wong RN: Methyl protodioscin induces G2/M arrest and apoptosis in K562 cells with the hyperpolarization of mitochondria. Cancer Lett. 224:229–241. 2005. View Article : Google Scholar : PubMed/NCBI
19	Tong QY, Qing Y, Shu D, et al: Deltonin, a steroidal saponin, inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis and antiangiogenesis. Cell Physiol Biochem. 27:233–242. 2011. View Article : Google Scholar : PubMed/NCBI
20	Shu D, Qing Y, Tong QY, et al: Deltonin isolated from Dioscorea zingiberensis inhibits cancer cell growth through inducing mitochondrial apoptosis and suppressing AKT and mitogen activated protein kinase signals. Biol Pharml Bull. 34:1231–1239. 2011.
21	Moon DO, Choi YH, Moon SK, et al: Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. Food Chem Toxicol. 49:999–1005. 2011.PubMed/NCBI
22	Zhang Z, Li M, Wang H, et al: Antisense therapy targeting MDM2 oncogene in prostate cancer: effects on proliferation, apoptosis, multiple gene expression and chemotherapy. Proc Natl Acad Sci USA. 100:11636–11641. 2003. View Article : Google Scholar : PubMed/NCBI
23	Edwards LA, Thiessen B, Dragowska WH, et al: Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis and delays tumor growth. Oncogene. 24:3596–3605. 2005. View Article : Google Scholar : PubMed/NCBI
24	Cossarizza A, Baccarani-Contri M, Kalashnikova G and Franceschi C: A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun. 197:40–45. 1993.PubMed/NCBI
25	Kroemer G, Zamzami N and Susin SA: Mitochondrial control of apoptosis. Immunol Today. 18:44–51. 1997. View Article : Google Scholar
26	Mitsopoulos P and Suntres ZE: Protective effects of liposomal N-Acetylcysteine against paraquat-induced cytotoxicity and gene expression. J Toxicol. 2011:1–14. 2011. View Article : Google Scholar : PubMed/NCBI
27	Konopleva M, Contractor R, Tsao T, et al: Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 10:375–388. 2006. View Article : Google Scholar : PubMed/NCBI
28	Nguyen TT, Tran E, Nguyen TH, et al: The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 25:647–659. 2004. View Article : Google Scholar : PubMed/NCBI
29	Cusimano A, Foderà D, D'Alessandro N, et al: Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway. Cancer Biother. 6:1461–1468. 2007.PubMed/NCBI
30	Kunnimalaiyaan M, Ndiaye M and Chen H: Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Surgery. 140:1009–1014. 2006. View Article : Google Scholar : PubMed/NCBI
31	Kong CS, Kimb JA, Yoon NY and Kim SK: Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem Toxicol. 47:1653–1658. 2009. View Article : Google Scholar : PubMed/NCBI
32	Haruna S, Kuroi R, Kajiwara K, Hashimoto R, Matsugo S, Tokumaruc S and Kojoa S: Induction of apoptosis in HL-60 cells by photochemically generated hydroxyl radicals. Bioorgan Med Chem Lett. 12:675–676. 2002. View Article : Google Scholar : PubMed/NCBI
33	Liu H, Xiao Y, Xiong C, Wei A and Ruan J: Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation. Eur J Pharmacol. 654:209–216. 2011. View Article : Google Scholar
34	Kim MJ, Liao J, Dowling ML, et al: TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. Cancer Res. 68:3440–3449. 2008. View Article : Google Scholar
35	Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
36	Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
37	Monteghirfo S, Tosetti F, Ambrosini C, et al: Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer Ther. 7:2692–2702. 2008. View Article : Google Scholar : PubMed/NCBI
38	Won SJ, Chung KS, Ki YS, Choi JH, Cho WJ and Lee KT: CWJ-081, a novel 3-arylisoquinoline derivative, induces apoptosis in human leukemia HL-60 cells partially involves reactive oxygen species through c-Jun NH2-terminal kinase pathway. Bioorgan Med Chem Lett. 20:6447–6451. 2010. View Article : Google Scholar
39	Han YM, Shin DS, Lee YJ, Ismail IA, Hong SH, Han DC and Kwon BM: 2-Hydroxycurcuminoid induces apoptosis of human tumor cells through the reactive oxygen species-mitochondria pathway. Bioorgan Med Chem Lett. 21:747–751. 2011. View Article : Google Scholar : PubMed/NCBI
40	Dillon RL, White DE and Muller WJ: The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene. 26:1338–1345. 2007. View Article : Google Scholar : PubMed/NCBI
41	Viglietto G, Motti ML, Bruni P, et al: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 (Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med. 8:1136–1144. 2002. View Article : Google Scholar
42	Brunet A, Bonni A, Zigmond MJ, et al: AKT promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
43	Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 57:353–361. 1994. View Article : Google Scholar : PubMed/NCBI
44	Li Y, Corradetti MN, Inoki K and Guan KL: TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci. 29:32–38. 2004. View Article : Google Scholar : PubMed/NCBI
45	Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002. View Article : Google Scholar : PubMed/NCBI
46	Fang JY and Richardson BC: The MAPK signaling pathways and colorectal cancer. Lancet Oncol. 6:322–327. 2005. View Article : Google Scholar : PubMed/NCBI